Home ▶ Vol 12, No 1 (2023) ▶ Mvelase

 

1. Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries: a systematic review and meta-analysis
Christelle Geneviève Jouego, Tom Decroo, Palmer Masumbe Netongo, Tinne Gils
BMJ Global Health  vol: 10  issue: 1  first page: e015977  year: 2025  
doi: 10.1136/bmjgh-2024-015977

2. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study
Ivan Barilar, Tatiana Fernando, Christian Utpatel, Cláudio Abujate, Carla Maria Madeira, Benedita José, Claudia Mutaquiha, Katharina Kranzer, Tanja Niemann, Nalia Ismael, Leonardo de Araujo, Thierry Wirth, Stefan Niemann, Sofia Viegas
The Lancet Infectious Diseases  vol: 24  issue: 3  first page: 297  year: 2024  
doi: 10.1016/S1473-3099(23)00498-X

3. Analysis of rpoB mutations associated with rifampicin resistance in Mycobacterium tuberculosis isolates in Malawi
Stewart Soko, Pizga Kumwenda
BMC Infectious Diseases  vol: 26  issue: 1  year: 2026  
doi: 10.1186/s12879-026-13126-8

4. Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes
Zegeye Bonsa, Mulualem Tadesse, Getu Balay, Wakjira Kebede, Gemeda Abebe
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases  vol: 34  first page: 100410  year: 2024  
doi: 10.1016/j.jctube.2023.100410

5. Undetected rifampicin-resistant tuberculosis associated with rpoB I491F and V170F mutations in Botswana: Diagnostic implications
Tuelo Mogashoa, Justice T. Ngom, Johannes Loubser, Kedumetse Seru, Tuduetso Molefi, One Stephen, Rosemary M. Musonda, Simani Gaseitsiwe, Robin M. Warren, Anzaan Dippenaar, Elizabeth M. Streicher, Sikhulile Moyo
Journal of Global Antimicrobial Resistance  vol: 46  first page: 171  year: 2026  
doi: 10.1016/j.jgar.2025.12.005

6. Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana
Tuelo Mogashoa, Johannes Loubser, Ontlametse T. Choga, Justice Tresor Ngom, Wonderful T. Choga, Mpaphi B. Mbulawa, Tuduetso Molefi, One Stephen, Topo Makhondo, Kedumetse Seru, Patience Motshosi, Boitumelo Zuze, Joseph Makhema, Rosemary M. Musonda, Dimpho Otukile, Chawangwa Modongo, Botshelo T. Kgwaadira, Keabetswe Fane, Simani Gaseitsiwe, Rob M. Warren, Sikhulile Moyo, Anzaan Dippenaar, Elizabeth M. Streicher
Frontiers in Microbiology  vol: 16  year: 2025  
doi: 10.3389/fmicb.2025.1535160

7. Therapeutic drug monitoring–guided treatment of XDR TB with an RpoB I491F mutation—a case report
Angela Klingmüller, Sylvia Zuber, Ada M Hoffmann, Niklas Köhler, Isabelle Suárez, Tim Preßel, Stefan Niemann, Viola Dreyer, Laurent A Decosterd, Eva Choong, Beatrice Schütz, Inna Friesen, Jan Rybniker
JAC-Antimicrobial Resistance  vol: 8  issue: 1  year: 2026  
doi: 10.1093/jacamr/dlaf251

8. Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India
Raj Narayan Yadav, Manpreet Bhalla, Shubhada Shenai, Surendra Kumar Sharma, Ritu Singhal
Indian Journal of Medical Microbiology  vol: 57  first page: 100925  year: 2025  
doi: 10.1016/j.ijmmb.2025.100925

9. Clinical, Radiological, and Molecular Profiles of Rifampicin-resistant Pulmonary Tuberculosis: A Cross-sectional Study from a Tertiary Referral Center in Indonesia
David Christianto, Ni Made Mertaniasih, Ariani Permatasari, Priyo Budi Purwono, Pepy Dwi Endraswari, Atika
Journal of Pure and Applied Microbiology  vol: 19  issue: 4  first page: 3095  year: 2025  
doi: 10.22207/JPAM.19.4.51

10. Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing
Shannon G. Murphy, Carol Smith, Pascal Lapierre, Joseph Shea, Kruthikaben Patel, Tanya A. Halse, Michelle Dickinson, Vincent Escuyer, Marie Claire Rowlinson, Kimberlee A. Musser
Frontiers in Public Health  vol: 11  year: 2023  
doi: 10.3389/fpubh.2023.1206056

11. The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023
Richard Anthony, Ramona Groenheit, Mikael Mansjö, Rina de Zwaan, Jim Werngren
Microorganisms  vol: 11  issue: 7  first page: 1809  year: 2023  
doi: 10.3390/microorganisms11071809

12. Decoding antibiotic resistance in tuberculosis: Role of RRDR and non-RRDR mutations in diagnostic perspectives
Risha Hazarika, Sanjukta Patra
Biochemical and Biophysical Research Communications  vol: 812  first page: 153563  year: 2026  
doi: 10.1016/j.bbrc.2026.153563

13. Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022
Phyu Win Ei, Mi Mi Htwe, Myat Htut Nyunt, Aye Su Mon, Zaw Myint, Wint Wint Nyunt, Su Mon Win, Sandar Aung, Wai Myat Thwe, Wah Wah Aung
Journal of Global Antimicrobial Resistance  vol: 41  first page: 169  year: 2025  
doi: 10.1016/j.jgar.2024.12.026